Neuronetics Reports Inducement Grant Under Nasdaq Listing
MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...
Stay updated with breaking news from Neuronetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing,...
STIM earnings call for the period ending June 30, 2022.
MALVERN, Pa. (AP) _ Neuronetics Inc. (STIM) on Tuesday reported a loss of $10.4 million in its second quarter. On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 39 cents.
Neuronetics Inc (NASDAQ:NASDAQ:STIM) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ETCompany ParticipantsMark Klausner - Investor RelationsKeith Sullivan - President &...
The FDA has cleared NeuroStar Advanced Therapy for Mental Health to treat anxiety symptoms in adults with major depressive disorder.